(Total Views: 825)
Posted On: 07/18/2020 10:55:13 PM
Post# of 145247
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
From the press release at incelldx it looks like Incelldx patented RANTES as a diagnostic on COVID 19 and has a deal from last August which entitles them to use Leronlimab as a diagnostic for receptor occupancy.. To answer your question IMO , of course he is getting regular updates from Amerax and its almost certainly great news!
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)